newsfilter
← Latest News
Business Wire·

Reata Announces the Appointment of Steven W. Ryder, M.D. to its Board of Directors

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) ("Reata," the "Company," or "we"), a clinical-stage biopharmaceutical company, today announced the appointment of Steven W. Ryder, M.D. to its Board of Directors, effective July 11, 2022. "We are thrilled to